Journal Article Ppublish 1 citation
PubMed: 39572402 DOI: 10.1111/bph.17392
Plasma miR-1-3p levels predict severity in hospitalized COVID-19 patients.
Br J Pharmacol 182(2):451-467
Authors: Paola Di Pietro, Angela Carmelita Abate, Carmine Izzo, Anna Laura Toni, Maria Rosaria Rusciano, Veronica Folliero, Federica Dell'Annunziata, Giovanni Granata, Valeria Visco, Benedetta Maria Motta, Alfonso Campanile, Carolina Vitale, Valeria Prete, Cristina Gatto, Giuliana Scarpati, Paolo Poggio, Gennaro Galasso, Pasquale Pagliano, Ornella Piazza, Gaetano Santulli, Gianluigi Franci, Albino Carrizzo, Carmine Vecchione, Michele Ciccarelli
Affiliations
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno, Baronissi, Italy.
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli", Naples, Italy.
- San Giovanni di Dio e Ruggi D'Aragona University Hospital, Salerno, Italy.
- Centro Cardiologico Monzino IRCCS, Milan, Italy.
- Department of Medicine, Division of Cardiology, Wilf Family Cardiovascular Research Institute, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Neuroimmunology and Inflammation, Albert Einstein College of Medicine, New York, New York, USA.
- Department of Advanced Biomedical Science, "Federico II" University, Naples, Italy.
- International Translational Research and Medical Education (ITME) Consortium, Naples, Italy.
- Department of Molecular Pharmacology, Einstein-Sinai Diabetes Research Center, Einstein Institute for Aging Research, Albert Einstein College of Medicine, New York, New York, USA.
- Vascular Physiopathology Unit, IRCCS Neuromed, Pozzilli, Italy.
MeSH
Drug Therapy, Covid-19, Pharmacology, Plasma
Cited by
- Aspirin reduces the risk of type 2 diabetes associated with COVID-19. npj metabolic health and disease.., 2025
- Imaging and Laboratory Results as Predictors of the Course of COVID-19. Adv Respir Med, 2025